ClinicalTrials.gov
public full text
Public Domain
Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19
The principal objective is to determine the impact of phenelzine on the activation phenotype of T cells and myeloid cells during SARS-CoV2 infection
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Utility of Lactoferrin as an Adjunct Therapeutic Agent for COVID-19#871590
- Novel Agents for Treatment of High-risk COVID-19 Positive Patients#832882
- SARS-CoV-2 Safety Study for the Treatment of COVID-19#895255
- T Cells Response to SARS COV 2 Peptides#969724
- The Effect of Berberine on Intestinal Function and Inflammatory Mediators in Severe Patients With Covid-19#1126753
Record · ID 803528
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive